VisLogic Closes Oversubscribed Beta, Bringing AI-Powered Digital Twins to SMBs at 1/10th the Cost VisLogic, Inc., the AI-native visual intelligence platform, announced today that its beta program closed three months early due to overwhelming demand, with users achieving first insights in under 10 minutes–versus days with traditional platforms. GlobeNewswire August 28, 2025 Phoenix, Arizona, Aug. […]

NEW YORK, NY / ACCESS Newswire / August 28, 2025 / If you suffered a loss on your Fiserv, Inc. (NYSE:FI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form?prid=164141&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE:EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. ("Dow" or the "Company") (NYSE:DOW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Dow and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation ("Redwire" or the "Company") (NYSE:RDW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Redwire and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE:CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September

NEW YORK, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. ("Barnes & Noble" or the "Company") (NYSE:BNED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Barnes & Noble